| The pretreatment platelet count is an independent predictor of tumor progression in patients undergoing transcatheter arterial chemoembolization with hepatitis B virus-related hepatocellular carcinoma | |
| Wang, Beili; Li, Feng; Cheng, Luya; Zhan, Yanxia; Wu, Boting; Chen, Pu; Shen, Junfei; Wu, Wenhao; Ma, Xiaolu; Zhu, Jie | |
| 刊名 | FUTURE ONCOLOGY
 |
| 2019 | |
| 卷号 | 15期号:8 |
| 关键词 | hepatocellular carcinoma platelet count prognosis time to progression transcatheter arterial chemoembolization |
| ISSN号 | 1479-6694 |
| URL标识 | 查看原文 |
| 语种 | 英语 |
| 内容类型 | 期刊论文 |
| URI标识 | http://www.corc.org.cn/handle/1471x/3597373 |
| 专题 | 复旦大学上海医学院 |
| 推荐引用方式 GB/T 7714 | Wang, Beili,Li, Feng,Cheng, Luya,et al. The pretreatment platelet count is an independent predictor of tumor progression in patients undergoing transcatheter arterial chemoembolization with hepatitis B virus-related hepatocellular carcinoma[J]. FUTURE ONCOLOGY,2019,15(8). |
| APA | Wang, Beili.,Li, Feng.,Cheng, Luya.,Zhan, Yanxia.,Wu, Boting.,...&Cheng, Yunfeng.(2019).The pretreatment platelet count is an independent predictor of tumor progression in patients undergoing transcatheter arterial chemoembolization with hepatitis B virus-related hepatocellular carcinoma.FUTURE ONCOLOGY,15(8). |
| MLA | Wang, Beili,et al."The pretreatment platelet count is an independent predictor of tumor progression in patients undergoing transcatheter arterial chemoembolization with hepatitis B virus-related hepatocellular carcinoma".FUTURE ONCOLOGY 15.8(2019). |
| 个性服务 |
| 查看访问统计 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论